BHHTalk | Female leaders in the health industry: challenges and opportunities”

March 10, 2023

Amazing talk by amazing women yesterday at Barcelona HealthHub quarters at Hospital de Sant Pau in Barcelona!!

On the occasion of International Women’s Day and within BHH Women´s Week, 5 female leaders who have made a mark in the healthcare industry gathered to discuss about challenges and opportunities that lie ahead in the sector.

Estrella García, Sr. Director Global Clinical Operations of Almirall, Mireia Cigarrán, Founder & CEO of VRPharma, Eva Molero, CEO of TeamIt Research,Clara Campàs, Managing Partner & Co-Founder of Asabys, and Asphalion´s Managing Director Núria Romero talked about their first-hand experience in the Healthcare industry.

Among many other topics, some of the highlights were the enrichment diversity brings, generating more value to companies; the good impact in terms of results that female led companies have, and the still existing gap between men and women in C-level positions, despite the growing number of women working in the Healthcare industry and in middle management positions. 

As closing remarks, Estrella highlighted that women still lack VISIBILITY to inspire, AMBITION to transform, SELF-CONFIDENCE to spread and convince, NETWORKING to help and MENTORING & ADVICE to guide them.

We would like to thank BHH for the invitation and the amazing speakers for their contributions and look forward to the next event!

Search News & Events

  • Filter by category

Share

Related news and events

NEW | IVDs Medical Devices Regulation

At European level, it has been considered necessary to establish a new solid, transparent, predictable and sustainable regulatory framework for in vitro diagnostic medical devices, that guarantees the highest level of safety and protection of patients and users health, and at the same time promotes innovation and the interests of small and medium-sized enterprises that carry out their activities in this sector.

WEBINAR RECORDING | Regulatory tips for Medical Device and IVD developers

Article 86 MDR requires manufacturers of Class IIa, Class IIb, and Class III devices to prepare a Periodic Safety Update Report (PSUR) for each device and, when relevant, for each category or group of devices. The MDCG 2022-21 guideline endorsed by the Medical Device Coordination Group (MDCG) provides ideas for manufacturers on how to prepare the PSUR for their Medical Devices.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting